跳至主要内容
临床试验/NCT01930773
NCT01930773Unknown3 期

Optimal P2Y12-receptor treatmeNt Guided by bedSIDe Genetic or Pharmacodynamic TESTing to Prevent Periprocedural Myonecrosis During Elective Percutaneous Coronary Intervention.

Medical University of Warsaw4 个研究点 分布在 2 个国家目标入组 150 人开始时间: 2013年3月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
发起方
入组人数
150
试验地点
4
主要终点
Prevalence of periprocedural myocardial injury within 24 h after PCI

研究概览

简要总结

Patients undergoing percutaneous coronary intervention with a residual high platelet reactivity despite oral clopidogrel are at increased risk of ischaemic complications. The strategies to overcome the issue consist of switch to a more potent antiplatelet medications including prasugrel or ticagrelor. Economic constrains of many countries still do not allow wide reimbursement of newer antiplatelet agents. Therefore a strategy to personalise treatment according to genotype and phenotype characteristics of the patient may provide an attractive solution combining high clinical efficacy with low budget impact.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 18-75
  • elective PCI

排除标准

  • acute coronary syndrome (troponin > 1 x ULN),
  • administration of glycoprotein IIb/IIIa inhibitors,
  • chronic total occlusion,
  • lesions with extensive calcifications requiring rotational atherectomy,
  • platelet count <70 000 /µl
  • high bleeding risk,
  • coronary bypass surgery in the previous 3 months,
  • severe chronic renal failure (eGFR < 30 mL/min)
  • requirement for warfarin, dabigatran, apixaban, rivaroxaban
  • history of stroke or TIA,
  • weight < 60 kg
  • known bleeding diathesis,
  • hematocrit of < 30% or >52%
  • pregnancy

研究组 & 干预措施

Genotyping Arm

Experimental

Rapid genotyping to select optimal P2Y12-inhibitor for PCI.

干预措施: Genotyping (Device)

Phenotying Arm

Experimental

The use of platelet function testing to select the optimal P2Y12-inhibitor for PCI.

干预措施: Phenotyping (Device)

Conventional Arm

No Intervention

Regular approach for performing elective PCI.

结局指标

主要结局

Prevalence of periprocedural myocardial injury within 24 h after PCI

时间窗: Within 24 hours after Percutaneous Coronary Intervention (PCI)

Post-procedural troponin value increase exceeding the 99th percentile upper reference limit (URL) within 24 hours after PCI

次要结局

  • Proportion of patients having periprocedural myocardial infarction (MI)(Within 24 hours or PCI)

研究者

发起方
Medical University of Warsaw
申办方类型
Other
责任方
Principal Investigator
主要研究者

Łukasz Kołtowski

Cardiology Researcher

Medical University of Warsaw

研究点 (4)

Loading locations...

相似试验